明德生物(002932.SZ)：前三季度净利润1351.55万元 同比减少83.30%

Core Viewpoint - Mingde Biological (002932.SZ) reported a slight increase in revenue for the first three quarters of 2025, but a significant decline in net profit compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 227 million yuan, representing a year-on-year increase of 0.53% [1] - The net profit attributable to shareholders was 13.52 million yuan, showing a year-on-year decrease of 83.30% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -63.33 million yuan [1] - Basic earnings per share stood at 0.0616 yuan [1]